Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotide therapy in cancer.

Alick C Stephens1, Rodney P A Rivers

  • 1Academic Department of Paediatrics, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London, W2 1PG, UK. a.stephens@imperial.ac.uk

Current Opinion in Molecular Therapeutics
|May 30, 2003
PubMed
Summary

Antisense oligonucleotides (ONs) are novel DNA-based therapeutics targeting specific gene activity. This review explores current strategies for using ONs in cancer therapy by targeting genes involved in apoptosis and cell growth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Dual-Cell-Tracker Dye Staining for the Identification and Characterization of Peanut-Specific T-Cell Subsets.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy.

The Journal of allergy and clinical immunology·2014
Same author

Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.

The Journal of allergy and clinical immunology·2014
Same author

IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy.

The Journal of allergy and clinical immunology·2014
Same author

Distribution of peanut protein in the home environment.

The Journal of allergy and clinical immunology·2013
Same author

Peanut protein in household dust is related to household peanut consumption and is biologically active.

The Journal of allergy and clinical immunology·2013

Area of Science:

  • Genomics and Molecular Biology
  • Pharmacology and Therapeutics
  • Oncology

Background:

  • Human genome sequencing reveals disease-associated genes.
  • New targeted therapeutics offer treatment opportunities.
  • Antisense oligonucleotides (ONs) are a promising class of drugs.

Purpose of the Study:

  • To review current strategies for antisense oligonucleotide (ON) targets in cancer therapy.
  • To highlight the potential of ONs in developing novel anticancer agents.

Main Methods:

  • Review of scientific literature on antisense oligonucleotide therapy.
  • Focus on ONs targeting genes regulating apoptosis, cell growth, metastasis, and angiogenesis.
  • Discussion of phosphorothioate antisense ONs as the current standard.

Related Experiment Videos

Main Results:

  • Antisense oligonucleotides (ONs) hybridize to target mRNA, blocking protein translation.
  • Specific gene targets in cancer regulation offer therapeutic potential.
  • Phosphorothioate ONs are the prevalent choice for current antisense therapy.

Conclusions:

  • Antisense oligonucleotides represent a highly specific therapeutic approach for cancer.
  • Targeting key genes in cancer pathways with ONs is a viable strategy.
  • Further development of ON-based therapies holds promise for cancer treatment.